Literature DB >> 32554512

Complex Movement Control in a Rat Model of Parkinsonian Falls: Bidirectional Control by Striatal Cholinergic Interneurons.

Cassandra Avila1, Aaron Kucinski1, Martin Sarter2.   

Abstract

Older persons and, more severely, persons with Parkinson's disease (PD) exhibit gait dysfunction, postural instability and a propensity for falls. These dopamine (DA) replacement-resistant symptoms are associated with losses of basal forebrain and striatal cholinergic neurons, suggesting that falls reflect disruption of the corticostriatal transfer of movement-related cues and their striatal integration with movement sequencing. To advance a rodent model of the complex movement deficits of Parkinsonian fallers, here we first demonstrated that male and female rats with dual cortical cholinergic and striatal DA losses (DL rats) exhibit cued turning deficits, modeling the turning deficits seen in these patients. As striatal cholinergic interneurons (ChIs) are positioned to integrate movement cues with gait, and as ChI loss has been associated with falls in PD, we next used this task, as well as a previously established task used to reveal heightened fall rates in DL rats, to broadly test the role of ChIs. Chemogenetic inhibition of ChIs in otherwise intact male and female rats caused cued turning deficits and elevated fall rates. Spontaneous turning was unaffected. Furthermore, chemogenetic stimulation of ChIs in DL rats reduced fall rates and restored cued turning performance. Stimulation of ChIs was relatively more effective in rats with viral transfection spaces situated lateral to the DA depletion areas in the dorsomedial striatum. These results indicate that striatal ChIs are essential for the control of complex movements, and they suggest a therapeutic potential of stimulation of ChIs to restore gait and balance, and to prevent falls in PD.SIGNIFICANCE STATEMENT In persons with Parkinson's disease, gait dysfunction and the associated risk for falls do not benefit from dopamine replacement therapy and often result in long-term hospitalization and nursing home placement. Here, we first validated a new task to demonstrate impairments in cued turning behavior in rodents modeling the cholinergic-dopaminergic losses observed in Parkinsonian fallers. We then demonstrated the essential role of striatal cholinergic interneurons for turning behavior as well as for traversing dynamic surfaces and avoiding falls. Stimulation of these interneurons in the rat model rescued turning performance and reduced fall rates. Our findings indicate the feasibility of investigating the neuronal circuitry underling complex movement control in rodents, and that striatal cholinergic interneurons are an essential node of such circuitry.
Copyright © 2020 the authors.

Entities:  

Keywords:  Parkinson's disease; acetylcholine; cortex; falls; interneurons; striatum

Year:  2020        PMID: 32554512      PMCID: PMC7392507          DOI: 10.1523/JNEUROSCI.0220-20.2020

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  116 in total

1.  Dopamine Deficiency Reduces Striatal Cholinergic Interneuron Function in Models of Parkinson's Disease.

Authors:  Jonathan W McKinley; Ziqing Shi; Ivana Kawikova; Matthew Hur; Ian J Bamford; Suma Priya Sudarsana Devi; Annie Vahedipour; Martin Darvas; Nigel S Bamford
Journal:  Neuron       Date:  2019-07-16       Impact factor: 17.173

2.  The rat prefrontostriatal system analyzed in 3D: evidence for multiple interacting functional units.

Authors:  Philippe Mailly; Verena Aliane; Henk J Groenewegen; Suzanne N Haber; Jean-Michel Deniau
Journal:  J Neurosci       Date:  2013-03-27       Impact factor: 6.167

3.  Reducing falls in Parkinson's disease: interactions between donepezil and the 5-HT6 receptor antagonist idalopirdine on falls in a rat model of impaired cognitive control of complex movements.

Authors:  Aaron Kucinski; Inge E M de Jong; Martin Sarter
Journal:  Eur J Neurosci       Date:  2016-08-18       Impact factor: 3.386

4.  Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine.

Authors:  G R Breese; T D Traylor
Journal:  Br J Pharmacol       Date:  1971-05       Impact factor: 8.739

5.  Executive dysfunction and attention contribute to gait interference in 'off' state Parkinson's Disease.

Authors:  Sue Lord; Lynn Rochester; Vicki Hetherington; Liesl M Allcock; David Burn
Journal:  Gait Posture       Date:  2009-11-05       Impact factor: 2.840

6.  Dysfunctional turning in Parkinson's disease.

Authors:  E Stack; A Ashburn
Journal:  Disabil Rehabil       Date:  2008       Impact factor: 3.033

7.  Basal forebrain chemogenetic inhibition disrupts the superior complex movement control of goal-tracking rats.

Authors:  Aaron Kucinski; Youngsoo Kim; Martin Sarter
Journal:  Behav Neurosci       Date:  2019-02       Impact factor: 1.912

8.  Sustained attention performance in rats with intracortical infusions of 192 IgG-saporin-induced cortical cholinergic deafferentation: effects of physostigmine and FG 7142.

Authors:  J McGaughy; M Sarter
Journal:  Behav Neurosci       Date:  1998-12       Impact factor: 1.912

9.  The relative contribution of physical and cognitive fall risk factors in people with Parkinson's disease: a large prospective cohort study.

Authors:  Serene S Paul; Catherine Sherrington; Colleen G Canning; Victor S C Fung; Jacqueline C T Close; Stephen R Lord
Journal:  Neurorehabil Neural Repair       Date:  2013-11-15       Impact factor: 3.919

10.  Falls and falls efficacy: the role of sustained attention in older adults.

Authors:  Aisling M O'Halloran; Nils Pénard; Alessandra Galli; Chie Wei Fan; Ian H Robertson; Rose Anne Kenny
Journal:  BMC Geriatr       Date:  2011-12-19       Impact factor: 3.921

View more
  9 in total

Review 1.  Cholinergic system changes in Parkinson's disease: emerging therapeutic approaches.

Authors:  Nicolaas I Bohnen; Alison J Yarnall; Rimona S Weil; Elena Moro; Mark S Moehle; Per Borghammer; Marc-André Bedard; Roger L Albin
Journal:  Lancet Neurol       Date:  2022-02-04       Impact factor: 44.182

Review 2.  Cholinergic systems, attentional-motor integration, and cognitive control in Parkinson's disease.

Authors:  Roger L Albin; Sygrid van der Zee; Teus van Laar; Martin Sarter; Cindy Lustig; Martijn L T M Muller; Nicolaas I Bohnen
Journal:  Prog Brain Res       Date:  2022-02-04       Impact factor: 2.453

Review 3.  Chemogenetics as a neuromodulatory approach to treating neuropsychiatric diseases and disorders.

Authors:  Jingwei Song; Ruchit V Patel; Massoud Sharif; Anagha Ashokan; Michael Michaelides
Journal:  Mol Ther       Date:  2021-12-01       Impact factor: 11.454

4.  Addressing the Challenges of Clinical Research for Freezing of Gait in Parkinson's Disease.

Authors:  Simon J G Lewis; Stewart A Factor; Nir Giladi; Mark Hallett; Alice Nieuwboer; John G Nutt; Serge Przedborski; Stella M Papa
Journal:  Mov Disord       Date:  2021-12-22       Impact factor: 10.338

5.  Anticholinergic Medication Use, Dopaminergic Genotype, and Recurrent Falls.

Authors:  Andrea L Rosso; Zachary A Marcum; Xiaonan Zhu; Nicolaas Bohnen; Caterina Rosano
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-05-05       Impact factor: 6.591

6.  Distinct morphology of cardiac- and brown adipose tissue-projecting neurons in the stellate ganglia of mice.

Authors:  Madeleine S Barrett; Deborah M Hegarty; Beth A Habecker; Sue A Aicher
Journal:  Physiol Rep       Date:  2022-05

Review 7.  Current approaches to characterize micro- and macroscale circuit mechanisms of Parkinson's disease in rodent models.

Authors:  Yangfan Peng; Nina Schöneberg; Maria Soledad Esposito; Jörg R P Geiger; Andrew Sharott; Philip Tovote
Journal:  Exp Neurol       Date:  2022-02-09       Impact factor: 5.620

8.  Reduction of falls in a rat model of PD falls by the M1 PAM TAK-071.

Authors:  Aaron Kucinski; Martin Sarter
Journal:  Psychopharmacology (Berl)       Date:  2021-03-18       Impact factor: 4.415

Review 9.  Make a Left Turn: Cortico-Striatal Circuitry Mediating the Attentional Control of Complex Movements.

Authors:  Martin Sarter; Cassandra Avila; Aaron Kucinski; Eryn Donovan
Journal:  Mov Disord       Date:  2021-02-22       Impact factor: 10.338

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.